PAMS
PRTK

Pictet Asset Management (Switzerland)’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-481,827
Closed -$930K – 1616
2022
Q2 		$930K Buy
481,827
+55,556
+13% +$107K ﹤0.01% 1047
2022
Q1 		$1.27M Buy
426,271
+91,227
+27% +$271K ﹤0.01% 1022
2021
Q4 		$1.5M Buy
335,044
+157,153
+88% +$705K ﹤0.01% 1019
2021
Q3 		$865K Buy
+177,891
New +$865K ﹤0.01% 1090